Personalis, Inc. (PSNL)
Healthcare • Diagnostics & Research
StockNasdaqGMUnited StatesUS71535D1063
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Personalis, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 14 Nov 2026 10:38. Information, not advice. Showing the last 90 days. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 25 Feb 2027 16:00 | -0.23 | — | — | Upcoming |
| 04 Nov 2026 16:00 | -0.25 | -0.32 | -26.3% | Miss |
| 04 Aug 2026 16:00 | -0.28 | -0.30 | -9.1% | Miss |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Older results and the annual figures: create a free account to see them
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 13 Nov 2026 | 15.90 | 15.94 | 15.58 | 15.71 | -0.95% | 2,803,800 | |
| 12 Nov 2026 | 15.90 | 15.95 | 15.81 | 15.86 | -0.63% | 1,864,800 | |
| 11 Nov 2026 | 15.90 | 16.04 | 15.90 | 15.96 | +0.50% | 1,139,000 | |
| 10 Nov 2026 | 15.88 | 16.07 | 15.81 | 15.88 | -0.44% | 1,755,200 | |
| 09 Nov 2026 | 15.80 | 16.00 | 15.80 | 15.95 | +1.01% | 2,323,900 | |
| 1,255 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Cancer Immunotherapy Drug Discovery Outsourcing - Global Strategic Business Report 2026: Capitalize on 13.5% CAGR to $2.4 Billion by 2032 Featuring Covance, Crown Bioscience, Personalis and Promega (opens in a new tab) 09 Nov 2026 15:40
- Did Wider Losses Just Shift Personalis (PSNL) Stock Investment Narrative? (opens in a new tab) Simply Wall St. · 07 Nov 2026 07:12
- Personalis: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 04 Nov 2026 21:28
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 15.86 USD
- Market cap
- 1.7B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow PSNL and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.